In addition, BTK inhibitors were found to be beneficial in treating human systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, Sjogren's disease, graft versus host disease, and idiopathic thrombocytopenic purpura [26]. The gene discussed is BTK; the disease is multiple sclerosis.